Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05981924
Other study ID # A2023-003
Secondary ID
Status Completed
Phase Phase 2
First received
Last updated
Start date August 1, 2023
Est. completion date April 20, 2024

Study information

Verified date May 2024
Source Sun Yat-sen University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To explore the feasibility and effectiveness of Perioperative Music Therapy Plus Oxycodone in pain management after thoracic surgery, patients will be randomly assigned into two groups. The experimental group will receive perioperative music therapy and the control group will not. We will record and contrast the postoperative oxycodone usage to evaluate the effect of music therapy in relieving the pain. We will also use visual analogue scale, questionnaire and EEG to evaluate patients' anxiety and depression.


Recruitment information / eligibility

Status Completed
Enrollment 66
Est. completion date April 20, 2024
Est. primary completion date January 20, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Enhanced CT or PET/CT indicate primary malignant pulmonary nodule; - The clinical stage belongs to cT1-4N0-2M0 before treatment or ycT1-4N0-2M0 after neoadjuvant treatment (AJCC/TNM 8th Edition); - Suitable for video-assisted thoracoscopic surgery after evaluated by thoracic surgeon; - FEV1 > 1.5L and DLCO > 60% pred; - Hearing loss lesser than 35 decibels (dB) in the better hearing ear; - Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to 2; - American Society of Anesthesiologists Score of 1 or 2; - Confirmed eligibility for R0 resection for curative intent by thoracic surgeon assessment; - Adequate cardiopulmonary function, confirmed to meet the requirement for surgical resection for curative intent; - Able to provide written informed consent and able to understand and agree to comply with study requirements and evaluation forms; - Life expectancy greater than 12 months Exclusion Criteria: - Enhanced CT or PET/CT indicate metastatic malignant pulmonary nodule; - Hearing loss greater than 35 decibels (dB) in the better hearing ear; - Active autoimmune disease or history of autoimmune disease that may recur; Note: well-controlled type 1 diabetes is allowed; hypothyroidism (controlled with thyroid hormone replacement only); well-controlled celiac disease; skin disease not requiring systemic treatment (eg, vitiligo, psoriasis, alopecia); any other condition that is not expected to recur in the absence of an external trigger. - History of interstitial lung disease, pneumonitis or uncontrolled systemic diseases, including diabetes, hypertension, pulmonary fibrosis, acute lung disease; - Serious infection occurred before grouping, including but not limited to hospitalization due to infectious complications, bacteremia or severe pneumonia; severe chronic or active infection (including pulmonary tuberculosis infection, etc.) requiring systemic (oral or intravenous) antibiotics within 14 days before grouping; - Simultaneous participation in another therapeutic clinical study; - Pregnant or lactating women, or male and female patients planning to have children during the study; - Other conditions that the investigators consider inappropriate for participation in this trial, such as poor compliance.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Perioperative Music Therapy
Music therapist will play customized music in the perioperative period on the basis of oxycodone analgesia

Locations

Country Name City State
China Sun Yat-sen University Cancer Center Guangzhou Guangdong

Sponsors (3)

Lead Sponsor Collaborator
Hao Long Sun Yat-sen University Department of Psychology, Sun Yat-sen University School of Art

Country where clinical trial is conducted

China, 

References & Publications (2)

Palmer JB, Lane D, Mayo D, Schluchter M, Leeming R. Effects of Music Therapy on Anesthesia Requirements and Anxiety in Women Undergoing Ambulatory Breast Surgery for Cancer Diagnosis and Treatment: A Randomized Controlled Trial. J Clin Oncol. 2015 Oct 1;33(28):3162-8. doi: 10.1200/JCO.2014.59.6049. Epub 2015 Aug 17. — View Citation

Zhou W, Ye C, Wang H, Mao Y, Zhang W, Liu A, Yang CL, Li T, Hayashi L, Zhao W, Chen L, Liu Y, Tao W, Zhang Z. Sound induces analgesia through corticothalamic circuits. Science. 2022 Jul 8;377(6602):198-204. doi: 10.1126/science.abn4663. Epub 2022 Jul 7. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The total dose of oxycodone within 72 hours after surgery The total dose of oxycodone within 72 hours after surgery 72 hours after surgery
Secondary The VSA-A Score The Visual Analogue Scale-Anxiety Score at different observation point 1 day before surgery, 1 hour before surgery, 24/48/72 hours after surgery
Secondary The VSA-P Score The Visual Analogue Scale-Pain Score at different observation point 24/48/72 hours after surgery
Secondary The incidence rate of analgesic related adverse reaction The incidence rate of analgesic related adverse reaction within 72 hours after surgery 72 hours after surgery
Secondary The usage of extra analgesics after surgery The usage of extra analgesics after surgery, such as Parecoxib, Tramadol or Morphine 72 hours after surgery
Secondary The kind and usage of anesthetics for anesthesia induction and maintenance The kind and usage of anesthetics for anesthesia induction and maintenance, such as Propofol, Sufentanil and Cisatracurium During the surgery
See also
  Status Clinical Trial Phase
Completed NCT03918538 - A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors N/A
Recruiting NCT05078918 - Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors N/A
Active, not recruiting NCT04548830 - Safety of Lung Cryobiopsy in People With Cancer Phase 2
Completed NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05583916 - Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery N/A
Completed NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Not yet recruiting NCT06376253 - A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers Phase 1
Recruiting NCT05898594 - Lung Cancer Screening in High-risk Black Women N/A
Active, not recruiting NCT05060432 - Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT03575793 - A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer Phase 1/Phase 2
Active, not recruiting NCT03667716 - COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. Phase 1
Terminated NCT01624090 - Mithramycin for Lung, Esophagus, and Other Chest Cancers Phase 2
Terminated NCT03275688 - NanoSpectrometer Biomarker Discovery and Confirmation Study
Not yet recruiting NCT04931420 - Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels Phase 2
Recruiting NCT06052449 - Assessing Social Determinants of Health to Increase Cancer Screening N/A
Recruiting NCT06010862 - Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors Phase 1
Not yet recruiting NCT06017271 - Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
Recruiting NCT05787522 - Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk